REYCHELLE MORALES: Open Payments
NPI 1699546218 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $513 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $143 |
| Amgen Inc. | 3 | $70 |
| Exact Sciences Corporation | 3 | $56 |
| ABBVIE INC. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $16 |
Products named: Wegovy, KRYSTEXXA, VRAYLAR, Ozempic, VOQUEZNA, Cologuard Collection Kit, MOUNJARO, REXULTI.
Industry payments across NV — which companies pay providers there.
